ARQT logo

Arcutis Biotherapeutics (ARQT) Company Overview

Profile

Full Name:

Arcutis Biotherapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 31, 2020

Indexes:

Not included

Description:

Arcutis Biotherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for dermatological diseases. The company was previously known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Our company is headquartered in Westlake Village, California. The company has a broad portfolio of drugs with significant potential for treating immune-mediated dermatological diseases and conditions. The company's lead product candidate is ARQ-151, a cream with roflumilast for the treatment of plaque psoriasis. The company is also developing ARQ-154, a roflumilast foam formulation for topical use to treat seborrheic dermatitis and scalp psoriasis. ARQ-252, a selective topical Janus kinase type 1 inhibitor for the treatment of chronic hand eczema and vitiligo. ARQ-255, a local formulation of ARQ-252, developed for deeper penetration into the skin to treat focal alopecia.

Key Details

Price

$14.72

Annual Revenue

$196.54 M(+229.74% YoY)

Annual EPS

-$1.16(+69.31% YoY)

Annual ROE

-113.76%

Beta

1.43

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Feb 25, 2025

Recent annual earnings:

Feb 25, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 27, 25 Goldman Sachs
Neutral
Feb 26, 25 Needham
Buy
Feb 26, 25 Mizuho
Outperform
Feb 26, 25 HC Wainwright & Co.
Buy
Feb 24, 25 Guggenheim
Buy
Feb 10, 25 Guggenheim
Buy
Jan 13, 25 HC Wainwright & Co.
Buy
Jan 7, 25 Mizuho
Outperform
Dec 30, 24 HC Wainwright & Co.
Buy
Dec 17, 24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Arcutis Biotherapeutics?
  • Does Arcutis Biotherapeutics pay dividends?
  • What sector is Arcutis Biotherapeutics in?
  • What industry is Arcutis Biotherapeutics in?
  • What country is Arcutis Biotherapeutics based in?
  • When did Arcutis Biotherapeutics go public?
  • Is Arcutis Biotherapeutics in the S&P 500?
  • Is Arcutis Biotherapeutics in the NASDAQ 100?
  • Is Arcutis Biotherapeutics in the Dow Jones?
  • When was Arcutis Biotherapeutics's last earnings report?
  • When does Arcutis Biotherapeutics report earnings?
  • Should I buy Arcutis Biotherapeutics stock now?

What is the ticker symbol for Arcutis Biotherapeutics?

The ticker symbol for Arcutis Biotherapeutics is NASDAQ:ARQT

Does Arcutis Biotherapeutics pay dividends?

No, Arcutis Biotherapeutics does not pay dividends

What sector is Arcutis Biotherapeutics in?

Arcutis Biotherapeutics is in the Healthcare sector

What industry is Arcutis Biotherapeutics in?

Arcutis Biotherapeutics is in the Biotechnology industry

What country is Arcutis Biotherapeutics based in?

Arcutis Biotherapeutics is headquartered in United States

When did Arcutis Biotherapeutics go public?

Arcutis Biotherapeutics's initial public offering (IPO) was on January 31, 2020

Is Arcutis Biotherapeutics in the S&P 500?

No, Arcutis Biotherapeutics is not included in the S&P 500 index

Is Arcutis Biotherapeutics in the NASDAQ 100?

No, Arcutis Biotherapeutics is not included in the NASDAQ 100 index

Is Arcutis Biotherapeutics in the Dow Jones?

No, Arcutis Biotherapeutics is not included in the Dow Jones index

When was Arcutis Biotherapeutics's last earnings report?

Arcutis Biotherapeutics's most recent earnings report was on Feb 25, 2025

When does Arcutis Biotherapeutics report earnings?

The next expected earnings date for Arcutis Biotherapeutics is May 14, 2025

Should I buy Arcutis Biotherapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions